*October 2024*
This is the recorded webinar discussing how immune cells can be engineered to target EGFR+ NSCLC. This webinar featured Jill Feldman and Laura Book, members of the EGFR Resisters, and Dr. Alexandre Reuben from the MD Anderson Cancer Center. Dr. Reuben is a 2023 EGFR Resisters/LUNGevity Foundation grant recipient who works on engineering T cells to treat several types of lung cancer. The discussion was moderated by Dr. Upal Basu Roy, Executive Director of Research at LUNGevity Foundation. Watch webinar here.
